Dermapharm Holding SE (DMPHF)
48.60
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Dermapharm Shareholders Equity (Quarterly) : 815.51M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bayer AG | 30.47B |
| Merck KGaA | 33.58B |
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.589B |
| Total Liabilities (Quarterly) | 1.765B |
| Debt to Equity Ratio | 1.515 |
| Current Ratio | 2.050 |
| Net Debt Paydown Yield | -0.86% |